Drug intelligence / Profile preview

silver oxide nanoparticles

Development stage
Preclinical
Modality
DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Inorganic Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Topical, Intravenous
01

Overview

Silver oxide nanoparticles are nanoscale particles composed of silver in its oxidized form (commonly Ag2O or AgO), typically ranging from 1 to 100 nanometers in size. They exhibit unique physicochemical properties distinct from bulk silver and other forms of silver compounds. Silver oxide nanoparticles are primarily investigated for their potent antimicrobial activity, including antibacterial, antifungal, and antiviral effects. Their mechanism of action involves the generation of reactive oxygen species (ROS), disruption of microbial cell membranes, and interference with essential proteins via interaction with thiol groups[8]. These properties make them promising candidates for use as pharmaceutical antibacterials, disinfectants, wound dressings, coatings for medical devices, and potential agents in drug delivery systems[2][8]. Research also explores their applications in cancer therapy due to cytotoxic effects on tumor cells while minimizing toxicity to healthy tissue[4][5]. The synthesis methods include chemical reduction and green synthesis using biological agents such as plant extracts or microbes for enhanced biocompatibility[8].

Other names
Ag2O nanoparticlesAg-2O nanoparticlesAg 2O nanoparticlesAgO nanoparticlesnanosilver oxide
02

Targets

bacterial dsDNA (Bacterial double-stranded DNA)

Beyond the preview

Go deeper on silver oxide nanoparticles.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on silver oxide nanoparticles.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call